FINWIRES · TerminalLIVE
FINWIRES

カナダの資源集約型地域では雇用は堅調だが、製造業の中心地では弱さが見られる、とBMOが発表

-- モントリオール銀行(BMO)によると、カナダの雇用者数は第1四半期に9万5000人減少し、新型コロナウイルス感染症のパンデミック以降で最も低調な落ち込みとなった。ただし、2025年第4四半期にはさらに大幅な増加が見込まれている。 金曜日に発表された労働力調査(LFS)を受けて、BMOは「過去1年間、雇用増加は非常に緩やかで、失業率はわずかに低下した」と指摘した。 しかし、BMOは「これは表面下で拡大している地域格差を覆い隠している」と述べている。 BMOは「オンタリオ州の失業率はニューファンドランド・ラブラドール州を除けば最も高く、7.6%となっている。これはカナダ全体との格差が(パンデミック以前では)過去最大に近い水準だ」と指摘した。 西部では、アルバータ州の失業率がブリティッシュコロンビア州を下回った。BMOは、2010年代半ばのエネルギーブーム以来、このような状況が持続的に見られることはないとしている。ブリティッシュコロンビア州、オンタリオ州、ケベック州を合わせた雇用者数は前年比0.4%減となった一方、アルバータ州では前年比4%増と成長が加速している。 カナダの都市における雇用市場の動向を見ると、資源産業が盛んなカルガリー、サスカトゥーン、エドモントン、レジャイナ、サドベリーが上位5都市を占め、明らかに好調だ。しかし、製造業の中心地であるロンドン、ウィンザー、セントキャサリンズ、バリー、キッチナーは下位5都市と、明らかに低迷している。 ロンドンの失業率9.1%は現在、カナダで最も高い。 こうした状況の一部は、労働力調査(LFS)における人口増加率の鈍化(特にオンタリオ州南部は非永住者受け入れ制限の影響を強く受けている)を反映している可能性があるが、これらの雇用市場の結果は、米中貿易摩擦や原油価格の高騰を背景としたBMOの広範な経済見通しと一致している。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB